HOME / Governmental News / STATE NEWS
TDI-DWC Publishes Designated Dr. Proposal
Rate This Article:
0
The Texas Department of Insurance, Division of Workers’ Compensation (TDI-DWC) is accepting comment on informally proposed new subsection 28 Texas Administrative Code (TAC) §127.130(b) regarding designated doctor’s qualification criteria for examinations performed on or after January 1, 2013. The informal proposal was published on December 19, 2011 and may be viewed on the TDI website at http://www.tdi.texas.gov/wc/rules/drafts.html. The comment period on the informal proposal closes Wednesday, January 11, 2012 at 5 p.m. Central Standard Time.

The TDI-DWC has made several changes to 28 TAC§127.130(b) in response to informal comments received on the informal draft of 28 TAC §127.130(b) that was published on October 14, 2011. The TDI-DWC is only seeking comments on 28 TAC §127.130(b) at this time.

This informal working draft is not a formal rule proposal. Accordingly, comments will not be treated as formal public comment for the purposes of the Administrative Procedure Act. In addition to commenting on this informal proposal, there will be the opportunity to formally comment on this subsection when the TDI-DWC formally proposes all of its amendments to 28 TAC Chapter 127 (relating to Designated Doctor Procedures and Requirements). The TDI-DWC anticipates formally publishing these amendments to Chapter 127, including 28 TAC §127.130(b), in the Texas Register in early 2012. The informal working draft may contain drafting notes and formatting which will be changed as necessary to comply with the Texas Register formatting.

Comments may be submitted by e-mailing InformalRuleComments@tdi.state.tx.us or by mailing or delivering the comments to:

Texas Department of Insurance, Division of Workers’ Compensation Maria Jimenez Workers’ Compensation Counsel MS-4D
7551 Metro Center Drive, Suite 100
Austin, Texas 78744-1645

If there are any questions regarding the information in this memo, contact Nicholas Gonzalez at 512-804-4277 or Nicholas.Gonzalez@tdi.state.tx.us

TITLE 28. INSURANCE
PART 2. TEXAS DEPARTMENT OF INSURANCE, DIVISION OF WORKERS’ COMPENSATION

CHAPTER 127 - DESIGNATED DOCTOR PROCEDURES AND REQUIREMENTS
SUBCHAPTER A - DESIGNATED DOCTOR SCHEDULING AND EXAMINATIONS NEW: §127.130(b)

INFORMAL - DRAFT

SUBCHAPTER A - DESIGNATED DOCTOR SCHEDULING AND EXAMINATIONS
§127.130. Qualification Standards for Designated Doctor Examinations.

(b) For examinations on or after January 1, 2013, a designated doctor is qualified to perform an initial designated doctor examination on an injured employee if the designated doctor meets the appropriate qualification criteria for the area of the body affected by the injury and the injured employee’s diagnosis and has no disqualifying associations under §127.140 of this title. A designated doctor’s qualification criteria are determined as follows:

(1) To examine injuries and diagnoses relating to the hand and upper extremities, a designated doctor must be a licensed medical doctor, doctor of osteopathy, or doctor of chiropractic.

(2) To examine injuries and diagnoses relating to the lower extremities excluding feet, a designated doctor must be a licensed medical doctor, doctor of osteopathy, or doctor of chiropractic.

(3) To examine injuries and diagnoses relating to the spine and torso, a designated doctor must be a licensed medical doctor, doctor of osteopathy, or doctor of chiropractic.

(4) To examine injuries and diagnoses relating to the feet, including the toes and heel, a designated doctor must be a licensed medical doctor, doctor of osteopathy, doctor of chiropractic, or doctor of podiatric medicine.

(5) To examine injuries and diagnoses relating to the teeth and jaws, a designated doctor must be a licensed medical doctor, doctor of osteopathy, or doctor of dental surgery.

(6) To examine injuries and diagnoses relating to the eyes, including the eye and adnexal structures of the eye, a designated doctor must be a licensed medical doctor, doctor of osteopathy, or doctor of optometry.

(7) To examine injuries and diagnoses relating to other body areas or systems, including but not limited to internal systems; ear, nose, and throat; head and face; skin; and mental and behavioral disorders, a designated doctor must be a licensed medical doctor or doctor of osteopathy.

(8) To examine any of the following diagnoses, a designated doctor must be a licensed medical doctor or doctor of osteopathy who has the required board certification. For purposes of this section, a medical doctor is “board certified” in a required specialty or subspecialty, as applicable, if the medical doctor holds a general certificate in the required specialty or a subspecialty certificate in the required subspecialty from the American Board of Medical Specialties. For the purposes of this section, a doctor of osteopathy is “board certified” in a required specialty or subspecialty, as applicable, if the doctor of osteopathy holds a primary certificate in the required specialty and a certificate of special qualifications or certificate of added qualifications in the required subspecialty from the American Osteopathic Association Bureau of Osteopathic Specialists.

(A) To examine traumatic brain injuries, spinal cord injuries, including spinal fractures with documented neurological deficit, and profound peripheral neuropathy, a designated doctor who is a medical doctor must be board certified in neurological surgery, neurology, physical medicine and rehabilitation, orthopaedic surgery, or occupational medicine. If a designated doctor is a doctor of osteopathy, the doctor must be board certified in neurological surgery, neurology, physical medicine and rehabilitation, orthopedic surgery, preventive medicine/occupational-environmental medicine, or preventive medicine/occupational;

(B) To examine severe burns, including chemical burns, defined as 3rd or 4th degree burns over 9 percent or greater of the body, a designated doctor who is a medical doctor must be board certified in dermatology, orthopaedic surgery, physical medicine and rehabilitation, plastic surgery, or occupational medicine. If a designated doctor is a doctor of osteopathy, the designated doctor must be board certified in dermatology, orthopedic surgery, physical medicine and rehabilitation, plastic and reconstructive surgery, preventive medicine/occupational-environmental medicine, or preventive medicine/occupational;

(C) To examine complex regional pain syndrome (reflex sympathetic dystrophy), a designated doctor who is a medical doctor must be board certified in neurological surgery, neurology, orthopaedic surgery, anesthesiology with a subspecialty in pain medicine, occupational medicine, or physical medicine and rehabilitation. If a designated doctor is a doctor of osteopathy, the designated doctor must be board certified in neurological surgery, neurology, orthopedic surgery, preventive medicine/occupational-environmental medicine, preventive medicine/occupational, anesthesiology with certificate of added qualifications in pain management, or physical medicine and rehabilitation;

(D) To examine multiple bone fractures, excluding spinal fractures, or dislocations and tendon lacerations, a designated doctor who is a medical doctor must be board certified in emergency medicine, orthopaedic surgery, plastic surgery, or occupational medicine. If a designated doctor is a doctor of osteopathy, the designated doctor must be board certified in emergency medicine, orthopedic surgery, plastic surgery, preventive medicine/occupational-environmental medicine, or preventive medicine/occupational;

(E) To examine complicated infectious diseases requiring hospitalization or prolonged intravenous antibiotics, including blood borne pathogens, a designated doctor who is a medical doctor must be board certified in internal medicine, occupational medicine, or family medicine. If a designated doctor is a doctor of osteopathy, the designated doctor must be board certified in internal medicine, preventive medicine/occupational-environmental medicine, preventive medicine/occupational, or family practice and osteopathic manipulative treatment;

(F) To examine chemical exposure, excluding chemical exposure limited to skin exposure, a designated doctor who is a medical doctor must be board certified in internal medicine, emergency medicine, occupational medicine, or family medicine. If a designated doctor is a doctor of osteopathy, the designated doctor must be board certified in internal medicine, emergency medicine, preventive medicine/occupational-environmental medicine, preventive medicine/occupational, or family practice and osteopathic manipulative treatment;

(G) To examine heart or cardiovascular conditions, a designated doctor who is a medical doctor must be board certified in internal medicine, emergency medicine, occupational medicine, or family medicine. If a designated doctor is a doctor of osteopathy, the designated doctor must be board certified in internal medicine, emergency medicine, preventive medicine/occupational-environmental medicine, preventive medicine/occupational, or family practice and osteopathic manipulative treatment.

 
Post A Comment
* Indicates Required Field
Comment Title:
* Comments:
Nickname:
* Validation:
Most Recent Comments
 
 
FeaturedNews
Clinical Trial Data Should Be Open for Review
Published 04/30/2012 - 3:14 p.m.  CDT

Original clinical study reports, which contain far more detail than published randomized trials, should be made available to independent researchers seeking to verify efficacy and safety claims.

In support of this argument, the history of the influenza antiviral oseltamivir (Tamiflu), which was approved by the FDA in 1999, was cited. The widespread belief in oseltamivir's efficacy, was based on a meta-analysis of 10 trials conducted by the manufacturer prior to licensure.  But the authors pointed out that the FDA, which was aware of these clinical trials, concluded that oseltamivir had not been shown to reduce complications and required a statement on the drug's label to that effect.  Moreover, oseltamivir was not given an FDA indication for prevention of spread of influenza.

To this, [authors] commented, "If FDA is right, the drug's effectiveness may be no better than aspirin or acetaminophen.'"
...Read More
HR 329 in need of Co Sponsors
Published 04/30/2012 - 11:11 a.m.  CDT

Representative Bob Filner recently introduced the Chiropractic Care to All Veterans Act (H.R. 329). The bill would require the Veterans Administration (VA) to have a chiropractic physician on staff at all major VA medical facilities by 2014. You too can help ensure chiropractic care is available to those who have placed their lives in service to our country. H.R. 329 is in need of cosponsors to assist its likelihood of passage.

CLICK HERE to urge your legislators to cosponsor the bill.
...Read More
Court Sides with Generic-Drug Makers
Published 04/25/2012 - 6:33 a.m.  CDT

In a unanimous decision, the Supreme Court ruled that generic drugmaker Caraco Pharmaceutical Laboratories can sue Novo Nordisk for what Caraco says are exaggerated descriptions of the scope of patents Novo Nordisk holds on a diabetes drug.

A group of Democratic senators has introduced a bill that would allow people to sue generic drugmakers over failing to update their drug labels to include all known risks. The bill is meant to counter last year's Supreme Court decision in a generic drug dispute.
...Read More
Reader Login
Username:
Password:
 Save Login?
Free Sign-up
Forgot Password?
Reader Control Panel

The TCA Web sites will be under going change in the next few weeks.  Please bear with us while we complete some improvements.

Original clinical study reports, which contain far more detail than published randomized trials, should be made available to independent researchers seeking to verify efficacy and safety claims.

In support of this argument, the history of the influenza antiviral oseltamivir (Tamiflu), which was approved by the FDA in 1999, was cited. The widespread belief in oseltamivir's efficacy, was based on a meta-analysis of 10 trials conducted by the manufacturer prior to licensure.  But the authors pointed out that the FDA, which was aware of these clinical trials, concluded that oseltamivir had not been shown to reduce complications and required a statement on the drug's label to that effect.  Moreover, oseltamivir was not given an FDA indication for prevention of spread of influenza.

To this, [authors] commented, "If FDA is right, the drug's effectiveness may be no better than aspirin or acetaminophen.'"

The Kilgore College Small Business Development Center (SBDC) will sponsor an educational seminar for medical office staff, including office managers and billing staff, entitled Basic Workers’ Compensation for Medical Office Staff on Wednesday, May 2, 2012.

Representative Bob Filner recently introduced the Chiropractic Care to All Veterans Act (H.R. 329). The bill would require the Veterans Administration (VA) to have a chiropractic physician on staff at all major VA medical facilities by 2014. You too can help ensure chiropractic care is available to those who have placed their lives in service to our country. H.R. 329 is in need of cosponsors to assist its likelihood of passage.

CLICK HERE to urge your legislators to cosponsor the bill.

An $8 billion Medicare demonstration program is poorly designed and should be cancelled, the nonpartisan Government Accountability Office (GAO) said. The program is designed to reward the highest-quality Medicare Advantage plans, but instead pays out most of its award money to mediocre plans, according to a report.


Ethiopia and Kenya Trips.  Have you ever wanted to provide chiropractic care in another country and give back to those in need?

Dr. Teresa Jones has been volunteering on mission trips to Africa for 4 years and is reaching out to the District 5 for help this year. There are two chances to participate, both in July 2012 and if you are interested please RSVP to frontdesk@wholehealth-care.com to let her know you area interested!


The Patient-Centered Outcomes Research Initiative (PCORI), established by the 2010 Patient Protection and Affordable Care Act, has set five priorities as the group's research agenda for the coming years, with the overall goal of advancing clinical effectiveness research. …. the priorities [are] as follows...

Girls who face multiple social stressors at home as toddlers are more likely to be obese by age 5, researchers found.

Nonpharmacologic pain management appears to be safe for mother and baby, although there is limited published evidence to explain its efficacy, according to a Cochrane Review.

There is more data to support the ef?cacy of pharmacologic pain management, such as epidurals and opioids, but these methods lead to more adverse effects.  This reports reports upon some of these
Regulators on both sides of the Atlantic were slow to inform patients and their doctors about problems with metal-on-metal hip implants and relied on industry officials and consultants in crafting their responses.

Complications included high failure rates and possible systemic effects from elevated metal ion levels in the blood.  An advisory has been issued to surgeons, telling them that patients who have received metal-on-metal implants should have annual checkups for life. The evaluations should include testing for metal ions in the blood as well as for clinical symptoms of device failure.